Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function.

Buchan SL, Dou L, Remer M, Booth SG, Dunn SN, Lai C, Semmrich M, Teige I, Mårtensson L, Penfold CA, Chan HTC, Willoughby JE, Mockridge CI, Dahal LN, Cleary KLS, James S, Rogel A, Kannisto P, Jernetz M, Williams EL, Healy E, Verbeek JS, Johnson PWM, Frendéus B, Cragg MS, Glennie MJ, Gray JC, Al-Shamkhani A, Beers SA.

Immunity. 2018 Nov 20;49(5):958-970.e7. doi: 10.1016/j.immuni.2018.09.014. Epub 2018 Nov 13.

PMID:
30446386
2.

Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking.

Turaj AH, Cox KL, Penfold CA, French RR, Mockridge CI, Willoughby JE, Tutt AL, Griffiths J, Johnson PWM, Glennie MJ, Levy R, Cragg MS, Lim SH.

Sci Rep. 2018 Feb 2;8(1):2278. doi: 10.1038/s41598-018-20656-y.

3.

Akt signaling is critical for memory CD8+ T-cell development and tumor immune surveillance.

Rogel A, Willoughby JE, Buchan SL, Leonard HJ, Thirdborough SM, Al-Shamkhani A.

Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1178-E1187. doi: 10.1073/pnas.1611299114. Epub 2017 Jan 30.

4.

Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization.

Willoughby JE, Kerr JP, Rogel A, Taraban VY, Buchan SL, Johnson PW, Al-Shamkhani A.

J Immunol. 2014 Jul 1;193(1):244-51. doi: 10.4049/jimmunol.1301217. Epub 2014 May 23.

5.

CD27 costimulation contributes substantially to the expansion of functional memory CD8(+) T cells after peptide immunization.

Taraban VY, Rowley TF, Kerr JP, Willoughby JE, Johnson PM, Al-Shamkhani A, Buchan SL.

Eur J Immunol. 2013 Dec;43(12):3314-23. doi: 10.1002/eji.201343579. Epub 2013 Oct 1.

6.

Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity.

Slebioda TJ, Rowley TF, Ferdinand JR, Willoughby JE, Buchan SL, Taraban VY, Al-Shamkhani A.

Eur J Immunol. 2011 Sep;41(9):2606-11. doi: 10.1002/eji.201141477. Epub 2011 Aug 4.

7.

Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.

Taraban VY, Slebioda TJ, Willoughby JE, Buchan SL, James S, Sheth B, Smyth NR, Thomas GJ, Wang EC, Al-Shamkhani A.

Mucosal Immunol. 2011 Mar;4(2):186-96. doi: 10.1038/mi.2010.70. Epub 2010 Oct 20.

8.

Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development.

Willoughby JE, Costello PS, Nicolas RH, Robinson NJ, Stamp G, Powrie F, Treisman R.

J Immunol. 2007 Nov 15;179(10):6836-44.

Supplemental Content

Loading ...
Support Center